<DOC>
	<DOCNO>NCT02102256</DOCNO>
	<brief_summary>Current treatment option bilateral profoundly deaf child , diagnose inner ear anatomical abnormality , limit , case absent cochlea , non-existent . An auditory brainstem implant ( ABI ) place electrode close auditory nucleus brainstem . Children age 2 - 5 candidate cochlear implant , demonstrate benefit cochlear implant , implant ABI follow 1 year safety total 3 year preliminary efficacy . This feasibility study determine safety ABI .</brief_summary>
	<brief_title>A Safety Study Auditory Brainstem Implant Pediatric Profoundly Deaf Patients</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Deafness</mesh_term>
	<mesh_term>Hearing Loss</mesh_term>
	<criteria>Bilateral profound deafness due cochlear aplasia , cochlear nerve deficiency , ossification secondary meningitis If previously receive cochlear implant , must demonstrate lack benefit device Medical contraindication craniotomy/intracranial surgery Severe cognitive developmental delay</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>deafness</keyword>
	<keyword>congenital</keyword>
	<keyword>pediatric</keyword>
	<keyword>device</keyword>
</DOC>